Recorded Chinese product: 曲安奈德新霉素贴膏曲安奈德新霉素贴膏

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

新霉素不少于单位是一种在国家药监局注册认定的药品。该药品含有相关活性成分。

该药品关联的活性成分包括:新霉素不少于单位Xinmei Subu Shaoyu Danwei。这些成分信息来自国家药监局数据库。

您可以探索含有相同成分的其他药品:新霉素不少于单位-44e3390b成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 曲安奈德新霉素贴膏) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.

Active ingredients associated with this product: 新霉素不少于单位Xinmei Subu Shaoyu Danwei.

Explore other medicines containing the same ingredient: 新霉素不少于单位 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 曲安奈德新霉素贴膏Recorded Chinese product: 曲安奈德新霉素贴膏
  • 剂型Dosage form: 膏剂Paste
  • 规格Specification: 4cm×6.5cm4cm × 6.5cm

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 锦州紫金药业有限公司Chinese legal name: 锦州紫金药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H21022726

关联实体Relationships

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H21022726

Manufacturer

Chinese legal name: 锦州紫金药业有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H21022726

生产企业

锦州紫金药业有限公司(国产)

适应症

本品用于局限性神经性皮炎,慢性湿疹。也可用于小面积的银屑病。

用法用量

外用。贴于患处。

不良反应

长期使用可出现类似肾上腺皮质功能亢进症,表现为多毛、痤疮、满月脸、高血压、骨质疏松、精神抑郁、伤口愈合不良。皮肤局部可发生萎缩、毛细血管扩张、色素沉着以及继发感染。

禁忌

1.对本品过敏者禁用。
2.皮肤破溃处禁用。
3.置于小儿不能接触到的地方。

注意事项

1.伴有细菌或病毒感染时应给予适当的抗感染治疗。
2.高血压、心脏病、骨质疏松症、肝肾功能不全者慎用。
3.置于小儿不能接触到的地方。

贮藏

密闭。

规格

4cm×6.5cm

证据Evidence

  • 批准文号: 国药准字H21022726
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.